Evidence map›Paper›PMID 39074161›Full record

ArticlePLoS genetics2024

Association of a rapidly selected 4.3kb transposon-containing structural variation with a P450-based resistance to pyrethroids in the African malaria vector Anopheles funestus.

Leon M J Mugenzi, Theofelix A Tekoh, Stevia T Ntadoun, Achille D Chi, Mahamat Gadji, Benjamin D Menze, Magellan Tchouakui, Helen Irving, Murielle J Wondji, Gareth D Weedall and 2 more

Abstract read
In one paragraph

Article in PLoS genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Leon M J MugenziLSTM Research Unit, Centre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.ORCID https://orcid.org/0000-0002-6857-9608
Theofelix A TekohLSTM Research Unit, Centre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.ORCID https://orcid.org/0009-0009-1781-782X
Stevia T NtadounLSTM Research Unit, Centre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.
Achille D ChiLSTM Research Unit, Centre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.
Mahamat GadjiLSTM Research Unit, Centre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.ORCID https://orcid.org/0000-0002-5671-2299
Benjamin D MenzeLSTM Research Unit, Centre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.
Magellan TchouakuiLSTM Research Unit, Centre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.
Helen IrvingVector Biology Department, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom.
Murielle J WondjiLSTM Research Unit, Centre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.
Gareth D WeedallVector Biology Department, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom.
Jack HearnVector Biology Department, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, United Kingdom.ORCID https://orcid.org/0000-0003-3358-4949
Charles S WondjiLSTM Research Unit, Centre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Deciphering the evolutionary forces controlling insecticide resistance in malaria vectors remains a prerequisite to designing molecular tools to detect and assess resistance impact on control tools. Here, we demonstrate that a 4.3kb transposon-containing structural variation is associated with pyrethroid resistance in central/eastern African populations of the malaria vector Anopheles funestus. In this study, we analysed Pooled template sequencing data and direct sequencing to identify an insertion of 4.3kb containing a putative retro-transposon in the intergenic region of two P450s CYP6P5-CYP6P9b in mosquitoes of the malaria vector Anopheles funestus from Uganda. We then designed a PCR assay to track its spread temporally and regionally and decipher its role in insecticide resistance. The insertion originates in or near Uganda in East Africa, where it is fixed and has spread to high frequencies in the Central African nation of Cameroon but is still at low frequency in West Africa and absent in Southern Africa. A marked and rapid selection was observed with the 4.3kb-SV frequency increasing from 3% in 2014 to 98% in 2021 in Cameroon. A strong association was established between this SV and pyrethroid resistance in field populations and is reducing pyrethroid-only nets' efficacy. Genetic crosses and qRT-PCR revealed that this SV enhances the expression of CYP6P9a/b but not CYP6P5. Within this structural variant (SV), we identified putative binding sites for transcription factors associated with the regulation of detoxification genes. An inverse correlation was observed between the 4.3kb SV and malaria parasite infection, indicating that mosquitoes lacking the 4.3kb SV were more frequently infected compared to those possessing it. Our findings highlight the underexplored role and rapid spread of SVs in the evolution of insecticide resistance and provide additional tools for molecular surveillance of insecticide resistance.

Indexed as

AnophelesCytochrome P-450 Enzyme SystemDNA Transposable ElementsInsecticide ResistanceInsecticidesMalariaMosquito VectorsPyrethrinsAnimalsCameroonHumansUgandaCytochrome P-450 Enzyme SystemDNA Transposable ElementsInsecticidesPyrethrins

Identifiers

PMID39074161
PMCPMC11309504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.